Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: -0.50 (-0.72%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 69.50
Low: 69.00
Prev. Close: 69.50
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re ProReveal

24 Jul 2013 07:01

RNS Number : 9861J
Scientific Digital Imaging Plc
24 July 2013
 

Scientific Digital Imaging Plc

 

Scientific Digital Imaging's ProReveal to be used to train professionals

at Eastwood Park

 

Cambridge, UK 24 July 2013: Scientific Digital Imaging (AIM: SDI, "SDI" or the "Company"), the AIM quoted group focused on the application of digital imaging technology to the needs of the scientific community, is pleased to announce that the major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to supplement the training of validation professionals on how to assess the efficacy of the decontamination processes.

 

The highly sensitive ProReveal, developed by SDI's Synoptics Health Division, is an in-situ fluorescence test which can detect nanogram levels of protein. It will be used on decontamination courses (compliant with EU and UK guidelines), to train senior personnel from UK and international decontamination validation and sterile services departments (SSDs).

 

Bruce Garbutt, Training Consultant at Eastwood Park said: "Protein decontamination is the ultimate in cleaning efficacy. If your process has removed protein you know your surgical instruments can be made safe to re-use. It is possible to infect patients with prion diseases like vCJD if the cleaning processes are not optimal and we have begun to realise how swab tests to detect prion levels can be flawed, hence the imperative for an 'in situ' test such as ProReveal."

 

Paul Ellwood, SDI Synoptics Health's CEO concluded: "Eastwood Park is a very progressive training centre and their adoption of the ProReveal test shows that they are preparing decontamination professionals to comply with the new quality standards. Their commitment to improving their decontamination processes will ensure professionals will be able to quickly and easily implement the ProReveal technology in their own facilities, to easily meet the upcoming minimum safe residual protein contamination guideline level being set by the Department of Health."

 

-Ends-

For Further Information Contact:

 

Scientific Digital Imaging:

 

Mike Creedon, Chief Executive of SDI - 01223 727144

Paul Ellwood, Chief Executive of Synoptics Health - 01223 727129

 

JW Communications

Julia Wilson, Investor & Public Relations - 0781 8430877

 

finnCap - 020 7220 0500

 

Ed Frisby/Rose Herbert -Corporate Finance

Simon Starr -Corporate Broking

 

 

 

Note to Editors

 

Scientific Digital Imaging Plc

Scientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. Within Synoptics, the recently formed Synoptics Health division has launched the Synoptics Health ProReveal system. This patented system offers a highly sensitive fluorescence-based test to detect dirty surgical instruments in hospitals and aims to reduce incidences of cross contamination of patients. In addition, under the Atik brand, SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications. www.scientificdigitalimaging.com

 

 

Eastwood Park

 

Eastwood Park in Gloucestershire, UK is widely acknowledged as a leading training centre, with an international reputation. It delivers specialist medical equipment, engineering, decontamination, facilities management and estates training, primarily to the healthcare and commercial facilities management sectors.

 

Most of the training offered is unique and is accredited by internationally recognised Awarding Bodies. Courses are regularly updated and new courses developed responding to new technologies, the latest official guidelines and individual sector developments.

 

Established 40 years, Eastwood Park maintains its commitment to delivering quality training as much today as the day it started in this vital sector.

www.eastwoodparktraining.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUORNROUABUAR
Date   Source Headline
19th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
13th Jan 20215:20 pmRNSExercise of Options and Total Voting Rights
12th Jan 20217:23 amRNSProgressive publishes new research
5th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
10th Dec 202010:20 amRNSDirector Dealing
10th Dec 20207:00 amRNSInvestor Presentation
9th Dec 20207:00 amRNSInterim Results
7th Dec 202011:06 amRNSSecond Price Monitoring Extn
7th Dec 202011:01 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSAcquisition of Monmouth Scientific Limited & TVR
26th Nov 20204:50 pmRNSExercise of Options and Total Voting Rights
28th Oct 20202:23 pmRNSChange of Website
22nd Oct 20207:00 amRNSTrading Update
23rd Sep 20202:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20202:00 pmRNSPrice Monitoring Extension
23rd Sep 202011:40 amRNSResult of AGM
23rd Sep 20207:00 amRNSAGM Trading Update & Investor Meet Company Q&A
3rd Sep 20204:24 pmRNSExercise of Options and Total Voting Rights
26th Aug 20204:49 pmRNSPosting of AR&A and Notice of AGM - Replacement
26th Aug 20204:11 pmRNSPosting of AR&A and Notice of AGM
17th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202010:51 amRNSDirector Dealing
21st Jul 20207:01 amRNSInvestor Presentation
21st Jul 20207:00 amRNSFinal Results
9th Jul 20207:00 amRNSNotice of Results
26th May 20202:06 pmRNSSecond Price Monitoring Extn
26th May 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSTrading & COVID-19 Update
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20203:10 pmRNSHolding(s) in Company
31st Jan 20201:19 pmRNSHolding(s) in Company
24th Jan 20203:29 pmRNSExercise of Options
27th Dec 20199:30 amRNSHolding(s) in Company
19th Dec 20191:14 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSAcquisition
31st Oct 20197:00 amRNSChange of Name
9th Oct 201910:43 amRNSExercise of Options
25th Sep 20194:55 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Update
20th Sep 20191:15 pmRNSDate of Annual General Meeting
3rd Sep 20195:46 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20197:04 amRNSDirector/PDMR Shareholding
18th Jul 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSTrading Update
15th May 20197:00 amRNSTrading Update
9th May 20197:00 amRNSSDI to present at Mello 2019
5th Apr 201911:02 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.